Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps
Author(s) -
A.C. Pinto Bezerra Soter,
T.F. Bezerra,
R. Pezato,
T.R. Teles Abdo,
R.M. Pilan,
F.R. Pinna,
P. Gevaert,
Thibaut Van Zele,
C. Bachert,
Richard Louis Voegels
Publication year - 2017
Publication title -
rhinology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.275
H-Index - 57
eISSN - 1996-8604
pISSN - 0300-0729
DOI - 10.4193/rhino15.291
Subject(s) - medicine , doxycycline , nerd , asthma , nasal polyps , sinusitis , nose , gastroenterology , prospective cohort study , chronic rhinosinusitis , nasal lavage , eosinophil , immunoglobulin e , surgery , antibiotics , immunology , disease , gerd , microbiology and biotechnology , biology , antibody , reflux
This study aimed to assess clinical outcomes of long-term low-dose oral doxycycline therapy in difficult-to-treat chronic rhinosinusitis with polyps (CRSwNP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom